4 European Projects Found
Searched on 125080 European Projects
FINISHED
Combatting Bacterial Resistance in Europe - Carbapenem Resistance (COMBACTE-CARE)
Start date: Mar 1, 2015, End date: Feb 28, 2020,
Multi-drug resistant Gram-negative bacteria (MDR-GNB): the ultimate challenge!Antibiotic resistance is a global public health concern recently elevated to the top three threats identified by the WHO, and subject of numerous national and international government activities. Although focused strategies have beneficially influenced infection rates due to methicillin resistant Staphylococcus aureus (M ...
Read Project
23
Partners Participants
FINISHED
Treatment of late onset bacterial sepsis caused by vancomycin susceptible bacteria in neonates and infants aged under three months (NEOVANC)
Start date: Feb 1, 2014, End date: Jan 31, 2019,
Vancomycin is the critically important antibiotic to treat neonatal Late Onset Sepsis (LOS) due to Gram positive bacteria in neonates, including Coagulase Negative Staphylococci (CoNS) and Staphylococcus aureus. These organisms also create biofilms which are extremely resistant to antibiotics. The increased incidence of LOS due to bacteria such as CoNS and MRSA in NICUs has led to a marked increas ...
Read Project
14
Partners Participants
FINISHED
Semantic Data Platform for Healthcare (SEMCARE)
Start date: Jan 1, 2014, End date: Dec 31, 2015,
The aim of SEMCARE is to build a semantic data platform to support clinical trials. The platform will identify patient cohorts based on patient-level criteria (e.g. age, gender, diagnosis, indication, symptoms, lab results) scattered in heterogeneous clinical data. As most of patient-level data is unstructured, language technologies are necessary to extract and exploit the relevant data. Our platf ...
Read Project
5
Partners Participants
FINISHED
Easy and rapid generation of light-emitting somatic-transgenic mice to monitor specific disease states and to screen effective drugs (SomaBio)
Start date: Dec 1, 2010, End date: Nov 30, 2015,
For decades, researchers have used small mammals to study the underlying processes of human disease and potential therapies for such ailments. Current strategies for measuring disease progression and/or drug effect usually involve groups of animals being killed at multiple time points for post-mortem tissue analysis. Recently, transgenic strains of mice have been created in which light-emitting lu ...
Read Project
